MedTrace Logo

Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse

NCT02921451 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-08-14

No results posted yet for this study

Summary

The purpose of this study is to determine the long term performance of Restorelle system for the treatment of uterine prolapse.

Conditions

  • Uterine Prolapse

Interventions

DEVICE

Restorelle Smartmesh

Patients will have surgery using the device, Restorelle Smartmesh, for treatment of uterine prolapse.

Sponsors & Collaborators

  • Coloplast A/S

    collaborator INDUSTRY

  • Michigan Institution of Women's Health PC

    lead OTHER

Principal Investigators

  • Salil Khandwala · Advanced Urogynecology of Michigan, P.C.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921451 on ClinicalTrials.gov